Citadel Advisors - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 85 filers reported holding ENZO BIOCHEM INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$84,747
-25.4%
60,534
-2.0%
0.00%
Q2 2023$113,613
-57.1%
61,746
-43.3%
0.00%
Q1 2023$264,586
+23.9%
108,883
-27.1%
0.00%
Q4 2022$213,608
+57.1%
149,376
+143.7%
0.00%
Q3 2022$136,000
+130.5%
61,291
+115.3%
0.00%
Q2 2022$59,000
+96.7%
28,465
+171.0%
0.00%
Q1 2022$30,000
-74.1%
10,502
-71.0%
0.00%
Q4 2021$116,000
-70.2%
36,180
-67.0%
0.00%
Q3 2021$389,000
-5.1%
109,747
-15.1%
0.00%
Q2 2021$410,000
+4.9%
129,310
+13.8%
0.00%
Q1 2021$391,000
+88.9%
113,602
+38.1%
0.00%
Q4 2020$207,000
+30.2%
82,235
+9.0%
0.00%
Q3 2020$159,000
+253.3%
75,448
+271.7%
0.00%
Q2 2020$45,000
-84.6%
20,300
-82.5%
0.00%
Q1 2020$293,000
+71.3%
115,815
+78.2%
0.00%
Q4 2019$171,000
-60.0%
64,993
-45.2%
0.00%
Q3 2019$427,000
+46.2%
118,516
+36.7%
0.00%
Q2 2019$292,000
+84.8%
86,668
+50.1%
0.00%
Q1 2019$158,000
-9.2%
57,748
-7.5%
0.00%
Q4 2018$174,000
-54.7%
62,431
-33.1%
0.00%
Q3 2018$384,000
-22.6%
93,327
-2.3%
0.00%
Q2 2018$496,000
-7.8%
95,482
-2.6%
0.00%
Q1 2018$538,000
+17.5%
98,080
+74.4%
0.00%
Q4 2017$458,000
+43.6%
56,241
+84.6%
0.00%
Q3 2017$319,000
-6.5%
30,463
-1.2%
0.00%
Q2 2017$341,000
+207.2%
30,827
+133.1%
0.00%
Q1 2017$111,000
-60.2%
13,223
-67.1%
0.00%
Q4 2016$279,000
+109.8%
40,231
+54.2%
0.00%
Q3 2016$133,000
-69.8%
26,083
-64.7%
0.00%
Q2 2016$441,000
+27.5%
73,823
-2.8%
0.00%
Q1 2016$346,000
+31.6%
75,951
+29.8%
0.00%
Q4 2015$263,000
+541.5%
58,499
+353.3%
0.00%
Q3 2015$41,000
-79.4%
12,904
-80.4%
0.00%
Q2 2015$199,000
-1.0%
65,801
-3.5%
0.00%
Q1 2015$201,000
-79.0%
68,187
-68.4%
0.00%
-100.0%
Q4 2014$958,000
+4.4%
215,919
+21.1%
0.00%0.0%
Q3 2014$918,000
+101.8%
178,287
+105.9%
0.00%0.0%
Q2 2014$455,000
+5.1%
86,590
-16.8%
0.00%0.0%
Q1 2014$433,000
+587.3%
104,030
+385.1%
0.00%
Q4 2013$63,000
+90.9%
21,445
+64.2%
0.00%
Q3 2013$33,000
+57.1%
13,059
+28.7%
0.00%
Q2 2013$21,00010,1450.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2020
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders